Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis

Ioana Petrescu1, Alexander C Egbe2, Filip Ionescu1

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Internal Medicine, Beaumont Health System, Royal Oak, Michigan.

Insights

Anticoagulation effectively treats bioprosthetic valve thrombosis (BPVT), but long-term outcomes show increased bleeding and re-BPVT risk. Patients with BPVT experienced higher rates of valve re-replacement, necessitating careful consideration of indefinite anticoagulation.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Medical Outcomes Research

Background:

  • Bioprosthetic valve thrombosis (BPVT) is a rare but serious complication after heart valve replacement.
  • While anticoagulation is effective for acute BPVT, long-term outcomes and risks remain incompletely understood.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes of patients diagnosed with bioprosthetic valve thrombosis (BPVT).
  • To assess the efficacy and safety of anticoagulation therapy in managing BPVT and its sequelae.

Main Methods:

  • A matched cohort study comparing 83 patients with BPVT treated with warfarin to 166 control subjects.
  • Matching criteria included age, sex, implantation year, and prosthesis type/position.
  • Median follow-up was 34 months.

Main Results:

  • Echocardiographic normalization occurred in 75% of BPVT patients within 3 months; 25% did not respond to warfarin.
  • No significant difference in the primary composite endpoint between BPVT patients and controls.
  • BPVT patients had a higher rate of major bleeding (12% vs. 2%) and valve re-replacement (68% vs. 24% at 10 years).
  • Recurrent BPVT (re-BPVT) occurred in 23% of responders, with most responding to further anticoagulation.

Conclusions:

  • Bioprosthetic valve thrombosis is associated with recurrent thrombosis and early prosthetic degeneration.
  • Indefinite warfarin anticoagulation may be considered for confirmed BPVT, balancing efficacy against increased bleeding risk.
  • Long-term monitoring and management strategies are crucial for patients with BPVT.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
222
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
167
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
188
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.5K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
276
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
213